{"id":143472,"date":"2023-05-10T00:00:00","date_gmt":"2023-05-09T13:48:47","guid":{"rendered":"https:\/\/www.mdbriefcase.com\/?post_type=eb_course&#038;p=143472"},"modified":"2023-12-04T14:39:01","modified_gmt":"2023-12-04T19:39:01","slug":"lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2","status":"publish","type":"eb_course","link":"https:\/\/www.mdbriefcase.com\/fr\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/","title":{"rendered":"Lung Cancer: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in Lung Cancer Therapy"},"content":{"rendered":"<p>Recent literature demonstrates that lung cancer represents around 4% of cancers diagnosed cancers in the Kingdom of Saudi Arabia (KSA). It is the 4th most common cancer in men and the 17th most common cancer in women.<\/p>\n<p>The objective of this online program is to help educate and support pharmacists in KSA in understanding the current landscape of lung cancer: genetic mutations, risk factors, and treatment approaches. The module reviews Saudi lung cancer management guidelines, discusses adverse events that may occur with treatment, and Saudi guidelines for the management of these adverse events.\n<\/p>\n<hr>\n<p>This program is supported by Novartis.<\/p>","protected":false},"featured_media":477867,"comment_status":"closed","ping_status":"closed","template":"","eb_course_cat":[],"class_list":["post-143472","eb_course","type-eb_course","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lung Cancer: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in Lung Cancer Therapy - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lung Cancer: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in Lung Cancer Therapy - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"Recent literature demonstrates that lung cancer represents around 4% of cancers diagnosed cancers in the Kingdom of Saudi Arabia (KSA). It is the 4th most common cancer in men and the 17th most common cancer in women. The objective of this online program is to help educate and support pharmacists in KSA in understanding the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-04T19:39:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2023\/05\/lung-x-ray-LP-18.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/\",\"name\":\"Lung Cancer: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in Lung Cancer Therapy - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2023\/05\/lung-x-ray-LP-18.jpg\",\"datePublished\":\"2023-05-09T13:48:47+00:00\",\"dateModified\":\"2023-12-04T19:39:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mdbriefcase.com\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/#primaryimage\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2023\/05\/lung-x-ray-LP-18.jpg\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2023\/05\/lung-x-ray-LP-18.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mdbriefcase.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Course\",\"item\":\"https:\/\/www.mdbriefcase.com\/courses\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Lung Cancer: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in Lung Cancer Therapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mdbriefcase.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lung Cancer: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in Lung Cancer Therapy - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/cours\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/","og_locale":"fr_CA","og_type":"article","og_title":"Lung Cancer: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in Lung Cancer Therapy - MDBriefCase","og_description":"Recent literature demonstrates that lung cancer represents around 4% of cancers diagnosed cancers in the Kingdom of Saudi Arabia (KSA). It is the 4th most common cancer in men and the 17th most common cancer in women. The objective of this online program is to help educate and support pharmacists in KSA in understanding the [&hellip;]","og_url":"https:\/\/www.mdbriefcase.com\/fr\/cours\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/","og_site_name":"MDBriefCase","article_modified_time":"2023-12-04T19:39:01+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2023\/05\/lung-x-ray-LP-18.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/","url":"https:\/\/www.mdbriefcase.com\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/","name":"Lung Cancer: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in Lung Cancer Therapy - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/#primaryimage"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2023\/05\/lung-x-ray-LP-18.jpg","datePublished":"2023-05-09T13:48:47+00:00","dateModified":"2023-12-04T19:39:01+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/#primaryimage","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2023\/05\/lung-x-ray-LP-18.jpg","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2023\/05\/lung-x-ray-LP-18.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/courses\/lung-cancer-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-lung-cancer-therapy-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Course","item":"https:\/\/www.mdbriefcase.com\/courses\/"},{"@type":"ListItem","position":3,"name":"Lung Cancer: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in Lung Cancer Therapy"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/143472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course"}],"about":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/eb_course"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=143472"}],"version-history":[{"count":0,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/143472\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media\/477867"}],"wp:attachment":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=143472"}],"wp:term":[{"taxonomy":"eb_course_cat","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course_cat?post=143472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}